Feed Companies Agents Subscribe

Loading...

Companies
Alivus Life Sciences Limited
Board Meeting

Board Meeting18-08-2026 · 05:28 pm IST·Outcome of Board Meeting

Alivus Life Sciences' board approved acquiring a 76% stake in IQGEN-X Pharma for ~₹9.12 Cr cash.

Alivus Life Sciences LimitedALIVUS · Filed with the exchange

This expands Alivus's offerings in the API & CDMO space, providing end-to-end solutions.

IQGEN-X specializes in pharmaceutical formulation development and reported FY26 turnover of ₹3.48 Cr.

Read the original filing(PDF)

No comments yet. Be the first.

More from Alivus Life Sciences Limited

All announcements

Investor Meet11-09-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Others08-09-2026
Shareholders meeting
Investor Meet07-09-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Meet05-09-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Meet25-08-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Updates18-08-2026
Press Release

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.